Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhNRG-1 for chronic stable heart failure
ACTRN12607000330448Phase 2Completed
- Sponsor
- Peter Macdonald
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Phase 2, open-label, single-arm trial of neucardin in heart failure (HF), sponsored by Peter Macdonald. Primary endpoints: Safety of rhNRG-1 and Left ventricular function and remodeling by MRI. Started Feb 2007; status: completed.
02
Drugs
neucardin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ACTRN12607000330448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000330448.